← Stock Trading Canary · All insider profiles
INSIDER PROFILE · UK
Giles Wilson
PDMR (Chief Financial Officer)
Profile key: uk|giles wilson
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 8
- Average purchase
- £27,235
- Gross purchase value
- £217,878
- Last purchase
- 2026-10-08
- Completed 20D events
- 7.0
- Outcome status
- PASS
Latest company: Dr. Martens plc
Companies: Dr. Martens plc
Post-purchase outcomes
Benchmark-relative outcomes are available against FTSE 100.
- Excess return = stock return − FTSE 100 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 8Developing | 100.0% (8/8) | 25.0% (2/8) | -1.6% | -1.1% | -5.5% |
| 20D | 7Developing | 100.0% (7/7) | 85.7% (6/7) | +0.8% | +2.6% | -6.4% |
| 60D | 7Developing | 100.0% (7/7) | 57.1% (4/7) | +10.4% | +7.0% | -23.3% |
| 120D | 6Developing | 100.0% (6/6) | 50.0% (3/6) | -6.3% | +8.7% | -41.6% |
Research patterns
- First purchase in 12M
- 0/8
- Large purchase ≥ €100k
- 1/8
- Cluster buying · 15D
- 7/8
- Buying the dip · ≥20% below prior 52W high
- 5/8
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.